SCHEMBL6304243

SCHEMBL6304243

COC(=O)c1ccc(Cl)c(OCCCl)c1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGER4 P35408 1/20 0.39
ABL1 P00519 1/20 0.39
HPD P32754 2/20 0.38
ALDH1A1 P00352 3/20 0.37
TSHR P16473 2/20 0.37
PTGS2 P35354 1/20 0.37
PDE3B Q13370 1/20 0.37
PDE3A Q14432 1/20 0.37
GAA P10253 1/20 0.37
KDM4E B2RXH2 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MAPT P10636 2/20 0.37
NPC1 O15118 1/20 0.37
NFKB1 P19838 1/20 0.37
RAB9A P51151 1/20 0.37
NFKB2 Q00653 1/20 0.37
RELA Q04206 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.36
LMNA P02545 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL587255 0.87 ABL1 (0.38) PTGER4ABL1HPDALDH1A1TSHR
SCHEMBL19700944 0.81 ALDH1A1 (0.41) PTGER4ABL1ALDH1A1TSHRPTGS2
SCHEMBL17689718 0.80 ABL1 (0.44) PTGER4ABL1ALDH1A1TSHRPTGS2
SCHEMBL8312122 0.79 HPD (0.36) HPDKDM4ENPC1L3MBTL1HDAC3
SCHEMBL24744904 0.77 ATR (0.41) PTGER4ABL1HPDALDH1A1TSHR
SCHEMBL30121806 0.77 ATR (0.41) PTGER4ABL1HPDALDH1A1TSHR
SCHEMBL587100 0.77 TP53 (0.44) PTGER4ALDH1A1TSHRGAAKDM4E
SCHEMBL10610948 0.76 ABL1 (0.49) PTGER4ABL1ALDH1A1TSHRPTGS2
SCHEMBL588042 0.75 CYP4F2 (0.46) ALDH1A1TSHRSMN1; SMN2NPC1MEN1
SCHEMBL8312126 0.75 HPD (0.34) HPDKDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6864219-B2 Substituted aryl ketones BAYER AKTIENGESELLSCHAFT (DE) 2005-03-08 US disclosed
US-20050009704-A1 Substituted aryl ketones SCHALLNER OTTO (DE) 2005-01-13 US disclosed
US-20030153465-A1 Substituted aryl ketones BAYER AKTIENGESELLSCHAFT (DE) 2003-08-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009704-A1 Substituted aryl ketones CBR3, CBR1, CYCS PTGER4 1342/4885ABL1 1199/4885HPD 1471/4885
US-20030153465-A1 Substituted aryl ketones CBR1, CBR3, CYCS PTGER4 1626/4885ABL1 1584/4885HPD 1459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.